vs

Side-by-side financial comparison of GERON CORP (GERN) and OP Bancorp (OPBK). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $24.3M, roughly 1.9× OP Bancorp). On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 13.7%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 11.4%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.

GERN vs OPBK — Head-to-Head

Bigger by revenue
GERN
GERN
1.9× larger
GERN
$47.2M
$24.3M
OPBK
Growing faster (revenue YoY)
GERN
GERN
+53.3% gap
GERN
67.1%
13.7%
OPBK
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
11.4%
OPBK

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
OPBK
OPBK
Revenue
$47.2M
$24.3M
Net Profit
$-18.4M
Gross Margin
Operating Margin
-29.4%
39.2%
Net Margin
-39.0%
Revenue YoY
67.1%
13.7%
Net Profit YoY
30.3%
EPS (diluted)
$-0.03
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
OPBK
OPBK
Q4 25
$24.3M
Q3 25
$47.2M
$24.5M
Q2 25
$49.0M
$23.7M
Q1 25
$39.6M
$22.2M
Q4 24
$21.3M
Q3 24
$28.3M
$20.7M
Q2 24
$882.0K
$20.4M
Q1 24
$304.0K
$19.6M
Net Profit
GERN
GERN
OPBK
OPBK
Q4 25
Q3 25
$-18.4M
$6.7M
Q2 25
$-16.4M
$6.3M
Q1 25
$-19.8M
$5.6M
Q4 24
Q3 24
$-26.4M
$5.4M
Q2 24
$-67.4M
$5.4M
Q1 24
$-55.4M
$5.2M
Operating Margin
GERN
GERN
OPBK
OPBK
Q4 25
39.2%
Q3 25
-29.4%
39.5%
Q2 25
-25.4%
35.7%
Q1 25
-42.2%
34.6%
Q4 24
31.2%
Q3 24
-99.8%
36.5%
Q2 24
-7860.9%
37.2%
Q1 24
-18465.1%
37.1%
Net Margin
GERN
GERN
OPBK
OPBK
Q4 25
Q3 25
-39.0%
27.4%
Q2 25
-33.4%
26.7%
Q1 25
-50.1%
25.0%
Q4 24
Q3 24
-93.5%
26.2%
Q2 24
-7639.8%
26.7%
Q1 24
-18220.4%
26.7%
EPS (diluted)
GERN
GERN
OPBK
OPBK
Q4 25
$0.48
Q3 25
$-0.03
$0.45
Q2 25
$-0.02
$0.42
Q1 25
$-0.03
$0.37
Q4 24
$0.33
Q3 24
$-0.04
$0.36
Q2 24
$-0.10
$0.36
Q1 24
$-0.09
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
OPBK
OPBK
Cash + ST InvestmentsLiquidity on hand
$78.1M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
$227.9M
Total Assets
$567.4M
$2.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
OPBK
OPBK
Q4 25
$167.3M
Q3 25
$78.1M
$166.7M
Q2 25
$77.7M
$205.4M
Q1 25
$83.7M
$198.9M
Q4 24
$134.9M
Q3 24
$60.3M
$166.8M
Q2 24
$116.9M
$127.7M
Q1 24
$189.8M
$139.2M
Stockholders' Equity
GERN
GERN
OPBK
OPBK
Q4 25
$227.9M
Q3 25
$248.7M
$221.5M
Q2 25
$259.5M
$213.7M
Q1 25
$268.2M
$210.1M
Q4 24
$205.0M
Q3 24
$292.3M
$203.6M
Q2 24
$306.7M
$195.9M
Q1 24
$344.9M
$194.7M
Total Assets
GERN
GERN
OPBK
OPBK
Q4 25
$2.7B
Q3 25
$567.4M
$2.6B
Q2 25
$555.2M
$2.6B
Q1 25
$562.5M
$2.5B
Q4 24
$2.4B
Q3 24
$444.9M
$2.4B
Q2 24
$449.4M
$2.3B
Q1 24
$482.1M
$2.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
OPBK
OPBK
Operating Cash FlowLast quarter
$-13.6M
$26.2M
Free Cash FlowOCF − Capex
$23.4M
FCF MarginFCF / Revenue
96.2%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$43.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
OPBK
OPBK
Q4 25
$26.2M
Q3 25
$-13.6M
$23.9M
Q2 25
$-27.4M
$-7.0M
Q1 25
$-48.0M
$5.6M
Q4 24
$31.2M
Q3 24
$-58.9M
$13.3M
Q2 24
$-53.5M
$15.8M
Q1 24
$-62.3M
$-3.2M
Free Cash Flow
GERN
GERN
OPBK
OPBK
Q4 25
$23.4M
Q3 25
$23.4M
Q2 25
$-7.7M
Q1 25
$4.2M
Q4 24
$29.7M
Q3 24
$12.8M
Q2 24
$-53.7M
$15.7M
Q1 24
$-62.9M
$-3.2M
FCF Margin
GERN
GERN
OPBK
OPBK
Q4 25
96.2%
Q3 25
95.6%
Q2 25
-32.5%
Q1 25
19.0%
Q4 24
139.0%
Q3 24
61.5%
Q2 24
-6086.6%
77.0%
Q1 24
-20680.3%
-16.6%
Capex Intensity
GERN
GERN
OPBK
OPBK
Q4 25
11.5%
Q3 25
2.3%
Q2 25
3.0%
Q1 25
6.4%
Q4 24
7.3%
Q3 24
0.0%
2.8%
Q2 24
23.4%
0.4%
Q1 24
202.3%
0.5%
Cash Conversion
GERN
GERN
OPBK
OPBK
Q4 25
Q3 25
3.57×
Q2 25
-1.10×
Q1 25
1.02×
Q4 24
Q3 24
2.45×
Q2 24
2.90×
Q1 24
-0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons